Showing results for
Vaccine Development

Omicron and vaccines - FAQ

Omicron and vaccines - FAQ

Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant

Vaccines shown to induce lower levels of neutralising antibodies against Omicron coronavirus variant

We can accelerate vaccine production through partnerships that promote knowledge sharing

We can accelerate vaccine production through partnerships that promote knowledge sharing

Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs

Com-COV2 study supports flexible second dose options following Pfizer or Oxford/AstraZeneca jabs

Oxford vaccine reaches two billion dose milestone

Oxford vaccine reaches two billion dose milestone

£200,000 funding boost for Oxford’s Clinical BioManufacturing Facility

£200,000 funding boost for Oxford’s Clinical BioManufacturing Facility

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Study reveals COVID-19 vaccine response in patients with impaired immune systems

Study reveals COVID-19 vaccine response in patients with impaired immune systems

Making a billion doses of vaccine in 18 months: starting with two tablespoons

Making a billion doses of vaccine in 18 months: starting with two tablespoons

African trial of novel HIV vaccine candidate starts

African trial of novel HIV vaccine candidate starts